Re-assessing the virological approach to HIV pathogenesis: Can it explain AIDS as an immunological disease?

Journal of Theoretical Biology

Volumn 187, Issue 1, 1997, Pages 45-56

  Whitaker, Rupert E D ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL LOSS; CLINICAL IMMUNOLOGY; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIROLOGY; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031558226     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1997.0416     Document Type: Article

References (100)

1. ALIMENTI, A., LUZURIAGA, K. et al. (1991). Quantitation of human immunodeficiency virus in vertically infected infants and children. J. Paediatr. 119, 225-229.
2. ALTERS, S. E., SHIZURU, J. A. et al. (1991). Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J. Exp. Med. 173(2), 491-494.
3. AOKI-SEI, S., YARCHOAN, R. et al. (1992). Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res. Hum. Retrovir. 8(7), 1263-1270.
4. BAGASRA, O., HAUPTMAN, S. P. et al. (1992). Detection of Human Immunodeficiency Virus Type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N. Eng. J. Med. 326(21), 1385-1391.
5. BAKER, R. (1995). News. Bulletin for the Experimental Treatment of AIDS. March 1995: 35.
6. BARRETT-BOYES, S. M., ROSSITTO, P. V. et al. (1992). Flow cytometric analysis of bluetongue virus infection in bovine blood mononuclear cells. J. Gen. Virol. 73(8), 1953-1960.
7. BELDA, A., ALBEROLA, V. et al. (1993). Kaposi's sarcoma with pulmonary involvement in a heterosexual man seronegative for the human immunodeficiency virus. Medicina Clinica 100(11), 437.
8. BERRY, R. M. & NOWAK, M. A. (1994). Defective escape mutants of HIV. J. Theor. Biol. 171(4), 387-395.
9. BISSET, L. R. (1994). Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle. Med. Hypoth. 43(6), 388-396.
10. BLAZQUEZ, M. V., MADUEÑO, J. A. et al. (1992). Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J. Immunol. 149(9), 3073-3077.
11. BOWDEN, F. J., MCPHEE, D. A. et al. (1991). Antibodies to gp41 and nef in otherwise HIV-negative homosexual man with Kaposi's sarcoma. Lancet 337(8753), 1313-1314.
12. BUCHWALD, D., CHENEY, P. R. et al. (1992). A chronic illness characterized by fatigue, neurologic, immunologic disorders, and active human herpesvirus 6 infection. Ann. Intern. Med. 116(2), 103-113.
13. COFFIN, J. M. (1995). HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
14. COHEN, J. (1993). AIDS: The unanswered questions. Science 260, 1253-1293.
15. CONCORDE CO-ORDINATING COMMITTEE (1994). Concorde: MRC/ ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343(8902), 871-880.
16. CONNOR, R. I., MOHRI, H. et al. (1992). Quantitation of HIV-1 in sequential blood samples from patients with precipitous decline in CD4 cell counts. J. Cell. Biochem. Suppl. 16E. 47.
17. COOMBS, R. W., COLLIER, A. C. et al. (1989). Plasma viremia in human immunodefiency virus infection. New Engl. J. Med. 321, 1626-1631.
18. COZON, G., GREENLAND, T. et al. (1990). Profound CD4+ T cell lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis. New Engl. J. Med. 332, 132.
19. CROWE, S. M., MILLS, J. et al. (1992). Human Immunodeficiency Virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: A possible mechanism of T lymphocyte depletion in vivo. Clin. Immunol. Immunopathol. 65(2), 143-151.
20. DALGLEISH, A. G. (1992). The pathogenesis of AIDS: Classical and alternative views. J. Royal Coll. Physicians Lond. 26(2), 152-158.
21. DALGLEISH, A. G. & COLIZZI, V. (1992). Role of major histo-compatibility complex recognition in the protection and immunopathogenesis of AIDS: Meeting Report. AIDS 6, 523-525.
22. DEL GUERCIO, P. (1989). AIDS and immune dysfunction: Alternative etiologic mechanisms. B Lymphocytes: Function and Regulation. Basel, Switzerland: Karger, S.
23. FAUCI, A. (1992). Editorial. Clin. Immunol. Spectrum 4(5), 1, 10.
24. FAUCI, A. S. (1991). Immunopathogenic mechanisms in human immunodeficiency virus infection. Ann. Intern. Med. 114(8), 678-692.
25. FENYÖ, E. M., ALBERT, J. et al. (1989). Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 3(Suppl.), 5-12.
26. FINKEL, T., TUDOR-WILLIAMS, G. et al. (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1(2), 129-134.
27. FRASSANITO, M. A., IODICE, G. RIZZI, R. & DAMMACCO, F, (1995). Idiopathic CD4+ lymphocytopenia: a case report. Ann. Ital. Med. Int. 10(3): 188-192.
28. FRIEDMAN, S. M., POSNETT, D. N. et al. (1991). A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthr. Rheum. 34(4), 468-480.
29. FRYER, K. M. C., DEACON, N. J. et al. (1992). Sequence and protein analysis of a rapidly replicating, non-syncytium-inducing HIV-1 isolate. J. Cell. Biochem. Suppl. 16E, 47.
30. lck share an overlapping region of CD4 for their function. J. Cell. Biochem. Suppl. 16E, 21.
31. GAUTIER, V., CHANEZ, P. et al. (1991). Unexplained CD4+ T cell deficiency in non-HIV patients presenting as a Pneumocystis carinii pneumonia. Clin. Exp. Allerg. 21, 63-66.
32. GLUCKMAN, J. C. (1996). [Immunopathological mechanisms of HIV infection]. Revue Med. Interne. 17(4), 313-320.
33. GOLDSCHMIDT, R. H., MOY A. (1996). Antiretroviral drug treatment for HIV/AIDS. Am. Fam. Phys. 54(2), 574-580, 587-588.
34. GOUDSMIT, J. (1994). HIV Variability and its Implications for Pathogenesis. Tenth International Conference on AIDS, Yokohama, Japan.
35. GRANT, M. D., WEAVER, M. S. et al. (1990). Distribution of antibodies against denatured collagen in AIDS risk groups and homosexual AIDS patients suggests a link between autoimmunity and the immunopathogenesis of AIDS. J. Immunol. 144(4), 1241-1250.
36. GUPTA, S., RIBAK, C. E. et al. (1992). Detection of a human intracisternal retroviral particle associated with CD4+ T-cell deficiency. Proc. Natl Acad. Sci. 89(16), 7831-7835.
37. HARPER, M. E., MARSELLE, L. M. et al. (1986). Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl Acad. Sci. 83, 772-776.
38. Ho, D. D., MOUDGIL, T. et al. (1989). Quantitation of Human Immunodeficiency Virus Type 1 in the blood of infected persons. New Engl. J. Med. 321, 1621-1625.
39. Ho, D., NEUMANN, A. et al. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
40. HOFFMAN, G. W. (1988). On I-J, a network centre pole, and AIDS. The Semiotics of Cellular Communication in the Immune System. pp. 257-272. Berlin: Springer-Verlag.
41. HOFFMANN, G. W. (1995). The T cell receptor and AIDS pathogenesis. Scand. J. Immunol. 41(4), 331-337.
42. HOOVER, D. R., RINALDO, C. et al. (1995). Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 × 10(6)/1. AIDS 9(2), 145-152.
43. HORIKOSHI, Y., MIMAYA, J. et al. (1994). Changes in Viral Load in HIV-infected Hemophiliacs. Tenth International Conference on AIDS, Yokohama, Japan.
44. HUGHES, M. D., STEIN, D. S. et al. (1994). Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: Implications for patient monitoring. J. Infec. Dis. 169(1), 28-36.
45. IMAGAWA, D. T., LEE, M. H. et al. (1989). Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. New Engl. J. Med. 320, 1458-1462.
46. JENNINGS, S. R., BONNEAU, R. H. et al. (1991). CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T-lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 133(1), 234-252.
47. JURRIAANS, S., DEKKER, J. T. et al. (1992). HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS 6, 635-641.
48. KION, T. & HOFFMAN, J. (1991). Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 253, 1138-1140.
49. KOOT, M., VAN LEEUWEN, R. et al. (1994). Prognostic Value of HIV-1 Biological Phenotype for Survival after AIDS Diagnosis. Tenth International Conference on AIDS, Yokohama, Japan.
50. KOWALSKI, M., BERGERON, L. et al. (1991). Attenuation of Human Immunodeficiency Virus Type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J. Virol. 65, 281-291
51. LAMBERT, M., VAN EGGERMOND, M. et al. (1991). Analysis of the peripheral T-cell compartment in the MHC Class II deficiency syndrome. Res. Immunol. 142, 789-798.
52. LAMBERT, M., VAN EGGERMOND, M. C. J. A. et al. (1990). The MHC Class II deficiency syndrome: Heterogeneity at the level of the response to 5-azadeoxycytidine. Res. Immunol. 141, 129-140.
53. LAURENCE, J., HODTSEV, A. S. et al. (1992). Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature 358, 255-259.
54. LECLERC, C., SCHUTZE, M. P. et al. (1990). The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression. J. Immunol. 145(5), 1343-1349.
55. LEMAITRE, M., GUETARD, D. et al. (1990). Protective activity of tetracycline analogs against the cytopathic effect of the Human Immunodeficiency Virus in CEM cells. Res. Virol. 141(1), 5-16.
56. LEMAITRE, M., HENIN, Y. et al. (1992). Role of mycoplasma infection in the cytopathic effect induced by Human Immunodeficiency Virus type 1 in infected cell lines. Infec. Immun. 60(3), 742-748.
57. LEONARD, J. M., ABRAMCZUK, J. W. et al. (1988). Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242, 1665-1670.
58. LEVY, J. A. (1988). Mysteries of HIV: challenges for therapy and prevention. Nature 333, 519-522.
59. LEWIS, D. E., MINSHALL, M. et al. (1990). Confocal microscopic detection of Human Immunodeficiency Virus RNA-producing cells. J. Infec. Dis. 162, 1373-1378.
60. LITTLEFIELD, J. W. (1992). Possible supplemental mechanisms in the pathogenesis of AIDS. Clin. Immunol. Immunopathol. 65(2), 85-97.
61. Lo, S. C., DAWSON, M. S. et al. (1989a). Identification of Mycoplasma incognitus in patients with AIDS: an immunohistochemical, in situ hybridisation and ultrastructural study. Am. J. Trop. Med. Hyg. 41, 601-616.
62. Lo, S. C., SHIH, J. W. et al. (1989b). Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Am. J. Trop. Med. Hyg. 41, 586-600.
63. Lo, S. C., TSAI, S. et al. (1991). Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 251, 1074-1076.
64. LOBATO, M. N., SPIRA, T. J. & ROGERS, M. F, (1995). CD4+ T lymphocytopenia in children: lack of evidence for a new acquired immunodeficiency syndrome agent. Pediatr. Infect. Dis. J. 6(14), 527-535.
65. MACKEWICZ, C. et al. (1994). Effect of zidovudine therapy on CD8 T-cell anti-HIV activity. Clin. Immunol. Immunopathol. 73(1), 80-87.
66. MARTIN, M. A. (1990). Fast-acting slow viruses. Nature 345, 572-573.
67. MASQUELIER, B., FAIVRE, R. et al. (1992). HIV-1 quantitation in infected patients: a comparison of cell viraemia, plasma viraemia, and R-HEV. Res. Virol. 143(1), 17-22.
68. MIEDEMA, F. (1992). Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodef. Rev. 3(3), 173-193.
69. MOSIER, D. E., GULIZIA, R. J. et al. (1992). Rapid loss of CD4+ T cells in human-PBL-SCID mice by non-cytopathic HIV isolates. Science 260(5108), 689-692.
70. NOWAK, M. A. (1992a). Variability of HIV infections. J. Theor. Biol. 155 (1) 1-20.
71. NOWAK, R. (1992b). Lab-bred HIV-1: Is it relevant? J. N.I.H. Res. 4, 33-34.
72. NOWAK, M. A., MAY, R. M. et al. (1995). Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375, (6532), 606-611.
73. OHASHI, D. K., CRANE, J. S., SPIRA, T. J. & COURREGE, M. L. (1994). Idiopathic CD4+ T-cell lymphocytopenia with verrucae, basal cell carcinomas, and chronic tinea corporis infection. J. Am. Acad. Dermatol. 31, 889-891.
74. PHILLIPS, A. N., LEE, C. A. et al. (1991). p24 antigenemia, CD4 lymphocyte counts and the development of AIDS. AIDS 5(10), 1217-1222.
75. PIATAK, M. et al. (1993). High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749-1754.
76. PLENARY (1996). Pathogenesis: Resolved that Viral Factors, and not Host Factors, are the Primary Determinants of Pathogenesis. Discussants: David Ho, Giuseppe Pantaleo. Eleventh Internatational Conference on AIDS, Vancouver, Canada. Thursday, July 11, 10-10.45 a.m.
77. RAPPERSBERGER, K., TSCHACHLER, E. et al. (1990). Endemic Kaposi's sarcoma in human immunodeficiency virus type-1 seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J. Invest. Dermatol. 95(4), 371-381.
78. REKA, S. & KOTLER, D. P. (1994). Comparison of HIV Viral Burden in Peripheral Blood and Rectal Mucosa. Tenth International Conference on AIDS, Yokohama, Japan.
79. ROOT-BERNSTEIN, R. S. & DEWITT S. H. (1994). CD4 similarity to proteins of infectious agents in AIDS and their role in autoimmunity. Med. Hypotheses 43(6), 361-371.
80. ROSENBERG, Z. F. & FAUCI, A. S. (1989). The immunopathogenesis of HIV infection. Adv. Immunol. 47, 377-431.
81. SAAG, M. S., HAMMER, S. M. & LANGE J. M. (1994). Pathogenicity and diversity of HIV and implications for clinical management: A review. J. AIDS 7(Suppl. 2), S2-10.
82. SAMSON, M., LIBERT, F. et al. (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles in the CCR-5 chemokine receptor gene. Nature 382(6593), 722-725.
83. SCHELLEKENS, P., TERSMETTE, M. et al. (1992). Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS 6, 665-669.
84. SKOWROWSKI, J., MARIANI, R. et al. (1992). Preferential depletion of CD4+ T cells in transgenic mice that express the HIV-1 nef gene. J. Cellular Biochem. 16E, 102.
85. SOMASUNDARAN, M. & ROBINSON, H. L. (1987). A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J. Virol. 61, 3114-3119.
86. SPIRA, T. J., JONES, B. M., NICHOLSON, J. K., LAL, R. B., ROWE, T., MAWLE, A. C. et al. (1993). Idiopathic CD4+ T-lympocytopenia - an analysis of five patients with unexplained opportunistic infections. N. Engl. J. Med. 6(328), 386-392.
87. STEVENSON, M., MEIER, C. et al. (1988). Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism of persistence in AIDS. Cell 53, 483-496.
88. STOOL, E., PIOT, D. et al. (1994). Opportunistic Infections in Patients with CD4 Counts Above 300. Tenth International Conference on AIDS, Yokohama, Japan.
89. TERSMETTE, M. & SCHUITEMAKER, H. (1993). Virulent HIV strains? AIDS 7(8), 1123-1125.
90. + cells in the lung. Am. J. Respir. Cell. Molec. Biol. 1(5), 391-400.
91. TWIGG, H. L., WEISSLE, R. J. C. et al. (1991). Monocyte accessory cell function in patients infected with the Human Immunodeficiency Virus. Clin. Immunol. Immunopathol. 59(3), 436-448.
92. VIA, C. S., MORSE, H. C. et al. (1990). Altered immunoregulation and autoimmune aspects of HIV infection: relevant murine models. Immunol. Today 11(7), 250-254.
93. WEI, X., GHOSH, S. et al. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature, 373, 117-122.
94. WHITAKER, R. E. D. (1990). Systems Dynamics Analysis of the Response to Viral Infection, with Particular Reference to the Acquired Immune Deficiency Syndrome. Boston University. Ph.D. Dissertation.
95. WOFSY, D. & SEAMAN, W. E. (1985). Successful treatment of autoimmunity in NZB/NZW f1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161, 378-391.
96. YAMANISHI, K. (1992). Pathogenesis of Human HerpesVirus 6 (HHV-6). Infec. Agents Dis. 1(3), 149-155.
97. Yu, X., McLANE, M. F. et al. (1994). Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1. Proc. Natl Acad. Sci. 91(21), 10237-10241.
98. ZAITSEVA, M. B., MOSHNIKOV, S. A. et al. (1992). Antibodies to MHC Class II peptides are present in HIV-1-positive sera. Scand. J. Immunol. 35, 267-273.
99. ZINKERNAGEL, R. (1994). Virus-induced immune deficiency disease AIDS: Direct pathogenic effect of the virus or immunopathology? Verhand. der Deutsch. Gesell. f. Pathol. 78, 166-170.
100. ZINKERNAGEL, R. M. (1995). Are HIV CTL responses salutary or pathogenic? Curr. Opin. Immunol. 4(7), 462-470.